Lapatinib Withdrawn Phase 2 Trials for Bladder Cancers / Urothelial Cancer Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01700010Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer